ChoKB Antibodies

Santa Cruz Biotechnology provides a broad selection of ChoKB Antibodies for advanced research in cellular signaling and metabolism. ChoKB Antibodies targeting ChoKB demonstrate high effectiveness in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ChoKB, or Choline Kinase Beta, plays a crucial role in the synthesis of phosphatidylcholine, a key component of cell membranes. ChoKB actively participates in cellular signaling pathways and influences various physiological processes, including cell proliferation and survival. Research has shown that ChoKB activity significantly impacts the development of cancer and neurodegenerative disorders. Scientists worldwide utilize ChoKB monoclonal antibodies to investigate cellular mechanisms and pathways. Understanding ChoKB function continues to reveal new insights into disease progression and potential treatments. Current research with ChoKB monoclonal antibodies advances scientific knowledge and supports the development of targeted therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies targeting ChoKB contribute to breakthrough discoveries that benefit the scientific community and medical research.